Sequent Scientific

133.77
-8.91
(-6.24%)
Market Cap
3,348.29 Cr
EPS
-1.44
PE Ratio
279.80
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
240.70
52 Week Low
92.05
PB Ratio
5.25
Debt to Equity
0.69
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,709.35
#1 4,10,130.32
36.01
#1 49,887.20
12.06
#1 9,648
13.77
49.12
5,482.85
1,45,552.44
74.00
8,184.00
0.89
1,600
#1 64.53
40.03
1,415.25
1,14,297.70
24.20
26,520.70
14.17
4,155
47.38
40.43
3,286.50
1,11,230.09
59.07
10,785.70
11.59
1,656
13.54
63.02
2,451.20
1,01,131.25
49.07
10,615.60
19.57
1,942
-16.38
58.29
1,109.95
92,620.37
#1 17.88
28,905.40
12.36
5,578
1.69
35.77
1,971.05
89,986.50
33.34
20,141.50
#1 19.94
1,936
38.82
44.59
866.90
87,230.42
20.00
19,831.50
13.82
3,831
29.92
38.62
1,105.35
64,198.91
19.37
29,559.20
17.55
3,169
-10.04
42.94
29,077.40
61,787.45
47.68
6,097.20
10.80
1,201
16.01
41.67
Growth Rate
Revenue Growth
-3.26 %
Net Income Growth
-75.74 %
Cash Flow Change
82.03 %
ROE
-74.51 %
ROCE
-93.16 %
EBITDA Margin (Avg.)
306.20 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
131
147
163
150
155
167
230
213
199
198
231
228
641
237
254
273
284
279
290
317
302
297
352
358
363
323
351
362
388
342
339
378
368
334
356
337
365
393
373
397
Expenses
130
128
137
144
143
157
208
201
176
178
179
210
213
213
224
235
243
240
247
266
256
250
300
291
319
300
331
322
350
342
335
365
432
365
331
307
334
348
334
357
EBITDA
1
19
26
6
12
10
22
12
22
20
52
19
428
24
30
38
41
40
43
51
47
47
52
67
45
23
20
40
37
-0
4
13
-63
-31
25
30
32
45
39
40
Operating Profit %
0 %
12 %
13 %
2 %
6 %
5 %
8 %
3 %
11 %
8 %
10 %
7 %
8 %
10 %
11 %
13 %
14 %
14 %
13 %
16 %
15 %
15 %
14 %
18 %
12 %
6 %
6 %
10 %
9 %
-0 %
1 %
3 %
-18 %
-10 %
4 %
7 %
8 %
11 %
9 %
9 %
Depreciation
10
9
9
11
16
13
16
13
10
10
10
12
10
10
10
11
11
12
13
13
13
13
13
12
13
13
13
13
13
14
13
14
15
14
15
16
17
16
17
17
Interest
11
11
8
8
10
8
9
8
7
6
7
10
10
8
8
8
9
9
8
10
9
8
7
6
3
3
3
4
6
7
8
10
11
11
13
13
12
16
14
15
Profit Before Tax
-16
1
8
-8
-15
-11
-2
-9
6
4
34
-3
409
7
12
18
22
19
23
28
24
26
32
50
29
7
4
24
18
-21
-18
-10
-89
-56
-3
2
3
12
8
8
Tax
3
1
1
1
0
1
2
2
-5
2
4
4
4
2
-3
3
0
4
-2
4
6
7
8
12
6
5
-10
5
8
-6
-13
-0
4
-21
4
-9
1
3
2
2
Net Profit
-19
-0
7
-8
-15
-12
-4
-11
11
2
31
-7
405
5
16
16
21
15
25
24
18
19
24
38
24
3
14
19
10
-15
-4
-10
-92
-35
-7
11
1
9
6
7
EPS in ₹
-7.09
0.01
1.27
-0.50
-0.55
-0.43
-0.22
-0.21
0.28
0.09
1.21
-0.39
0.14
0.14
0.63
0.54
0.71
0.47
0.88
0.83
0.69
0.93
0.86
1.45
0.84
0.04
0.58
0.69
0.36
-0.60
-0.15
-0.36
-3.77
-1.40
-0.34
0.33
-0.04
0.26
0.11
0.14

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
908
1,528
1,905
1,343
1,388
1,463
1,393
1,451
1,529
1,540
Fixed Assets
474
587
684
476
498
577
536
564
605
592
Current Assets
310
491
728
538
600
704
714
783
780
811
Capital Work in Progress
39
24
33
18
23
13
31
12
55
16
Investments
1
428
428
239
180
172
83
38
0
4
Other Assets
394
491
760
610
687
701
744
837
869
929
Total Liabilities
908
1,528
1,905
1,343
1,388
1,463
1,393
1,451
1,529
1,540
Current Liabilities
406
290
664
431
434
495
460
512
559
627
Non Current Liabilities
264
290
247
227
207
236
156
199
221
200
Total Equity
238
948
994
685
747
732
776
740
749
713
Reserve & Surplus
32
885
928
599
657
637
678
633
649
607
Share Capital
31
48
49
49
49
50
50
50
50
50

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
-2
24
-5
28
0
-14
4
-16
23
Investing Activities
-157
-311
-116
7
-68
-72
10
-94
-65
-6
Operating Activities
-24
-0
-7
45
116
115
115
31
17
31
Financing Activities
179
309
147
-57
-20
-43
-139
67
32
-1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
53.86 %
53.86 %
53.52 %
53.02 %
53.02 %
52.79 %
52.79 %
52.79 %
52.79 %
52.79 %
52.79 %
52.79 %
52.79 %
52.78 %
52.76 %
52.61 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
6.03 %
0.00 %
6.16 %
5.70 %
6.45 %
6.10 %
DIIs
2.68 %
2.11 %
1.49 %
0.51 %
0.30 %
0.29 %
1.66 %
2.81 %
2.92 %
2.92 %
3.23 %
5.02 %
7.59 %
8.06 %
9.99 %
12.02 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
19.28 %
19.04 %
19.57 %
26.31 %
27.64 %
28.20 %
27.92 %
28.61 %
29.03 %
28.85 %
29.25 %
25.11 %
24.43 %
25.01 %
24.00 %
23.82 %
Others
24.19 %
25.00 %
25.42 %
20.17 %
19.04 %
18.72 %
17.63 %
15.80 %
15.26 %
15.44 %
8.70 %
17.08 %
9.02 %
8.45 %
6.80 %
5.46 %
No of Share Holders
0
62,318
86,848
1,24,014
1,67,812
1,91,092
1,97,176
1,93,954
1,96,231
1,87,474
1,84,521
1,72,853
1,66,593
1,63,693
1,54,603
1,62,574

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.2 0.2 0.00 0.5 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.28 0.26 0.00 0.37 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Registered Office Of The Company Has Been Shifted From Maharashtra To Telangana3 days ago
Closure of Trading Window8 days ago
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 (Listing Regulations)Mar 11, 2025
Update - Shifting Of Registered OfficeMar 11, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 11, 2025
Integrated Filing (Financial)Feb 11, 2025
Outcome Of Board Meeting Held On February 11 2025 Along With Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 11, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On February 11 2025 Along With Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 04, 2025
Intimation Under Regulation 30 Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 01, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJan 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 21, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 20, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Closure of Trading WindowDec 31, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 27, 2024
Appointment of Company Secretary and Compliance OfficerDec 16, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerDec 16, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateDec 16, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 02, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportNov 29, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 25, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 22, 2024
Announcement under Regulation 30 (LODR)-Updates on AcquisitionNov 22, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 14, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2024
Board Meeting Outcome for Q2FY25 ResultsNov 13, 2024
Q2FY25 ResultsNov 13, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2024
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Nov 06, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 05, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 30, 2024
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 29, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateOct 28, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 17, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 14, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 09, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 04, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 02, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationSep 27, 2024
Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements), 2015 - Board Approves Change In The Registered Office And Consequent Amendment To The Memorandum Of Association Of The CompanySep 26, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 26, 2024
Announcement under Regulation 30 (LODR)-Scheme of ArrangementSep 26, 2024
Closure of Trading WindowSep 26, 2024

Technical Indicators

RSI(14)
Neutral
41.44
ATR(14)
Volatile
8.09
STOCH(9,6)
Neutral
29.29
STOCH RSI(14)
Neutral
78.52
MACD(12,26)
Bullish
0.50
ADX(14)
Weak Trend
24.45
UO(9)
Bearish
40.21
ROC(12)
Downtrend And Accelerating
-3.89
WillR(14)
Neutral
-79.80